A Better Route For Commercial Manufacture: Improved Yields And Operability
Source: Asymchem
Early development routes are often unsuitable for large scale commercial manufacture. A new chemical process improved yields and operability.
Challenge
A new process was needed for the commercial manufacturing of Ceralasertib, an experimental anti-cancer therapy with a challenging molecular structure comprised of a pyrimidine core decorated with a chiral morpholine, a cyclopropyl sulfoximine and an axaindote.
access the Case Study!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.
Subscribe to Pharmaceutical Online
X
Subscribe to Pharmaceutical Online
This website uses cookies to ensure you get the best experience on our website. Learn more